Prevention of Coronary Vascular Disease by Transplantation of T-Cell-Depleted Bone Marrow and Hematopoietic Stem Cell Preparation in Autoimmune-Prone W/BF1 Mice

Biology of Blood and Marrow Transplantation

Volumn 6, Issue 5, 2000, Pages 513-522

  Kirzner, Rosemarie P ^a,d   Engelman, Robert W ^b   Mizutani, Hajime ^c   Specter, Steven ^a   Good, Robert A ^b  

^a UNIVERSITY OF SOUTH FLORIDA   (United States)

^b UNIVERSITY OF SOUTH FLORIDA   (United States)

^c OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

^d BROOKE ARMY MEDICAL CENTER   (United States)

Author keywords

Autoimmune; Bone marrow transplantation; Coronary vascular disease

Indexed keywords

ANIMAL; ANIMAL MODEL; ARTICLE; AUTOIMMUNE DISEASE; BAGG ALBINO MOUSE; BONE MARROW TRANSPLANTATION; CORONARY ARTERY DISEASE; CROSS BREEDING; CYTOLOGY; CYTOTOXIC T LYMPHOCYTE; FLOW CYTOMETRY; HEMATOPOIETIC STEM CELL TRANSPLANTATION; LUPUS ERYTHEMATOSUS NEPHRITIS; LYMPHOCYTE ACTIVATION; LYMPHOCYTE DEPLETION; MALE; MIXED LYMPHOCYTE CULTURE; MOUSE; MOUSE STRAIN; MURPHY ROTHS LARGE LYMPHOPROLIFERATIVE MOUSE; NEW ZEALAND BLACK MOUSE; PATHOLOGY; RADIATION CHIMERA; ROSETTE FORMATION; SPLEEN; SYSTEMIC LUPUS ERYTHEMATOSUS;

ANIMALS; AUTOIMMUNE DISEASES; BONE MARROW TRANSPLANTATION; CORONARY DISEASE; CROSSES, GENETIC; FLOW CYTOMETRY; HEMATOPOIETIC STEM CELL TRANSPLANTATION; LUPUS ERYTHEMATOSUS, SYSTEMIC; LUPUS NEPHRITIS; LYMPHOCYTE ACTIVATION; LYMPHOCYTE CULTURE TEST, MIXED; LYMPHOCYTE DEPLETION; MALE; MICE; MICE, INBRED BALB C; MICE, INBRED MRL LPR; MICE, INBRED NZB; MICE, INBRED STRAINS; MODELS, ANIMAL; RADIATION CHIMERA; ROSETTE FORMATION; SPLEEN; T-LYMPHOCYTES, CYTOTOXIC;

EID: 0034571956     PISSN: 10838791     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1083-8791(00)70022-X     Document Type: Article

References (29)

1. 1 hybrid: a model of acute lupus and coronary vascular disease with myocardial infarction. J Exp Med. 1981;154:216-221.
2. 1 mouse: a new animal model of idiopathic thrombocytopenic purpura. J Exp Med. 1988;167:2017-2022.
3. 1 male mice. Am J Pathol. 1989;135:989-999.
4. 1 hybrid mice with systemic lupus erythematosus and small coronary artery disease. Am J Pathol. 1987;129:477-485.
5. 1 mice by haploidentical bone marrow transplantation: possible role for anticardiolipin antibodies. Blood. 1993;82:3091-3097.
6. Hang L, Stephen-Larson P, Henry JP, Dixon F. Transfer of renovascular hypertension and coronary heart disease by lymphoid cells from SLE-prone mice. Am J Pathol. 1984;115:42-46.
7. Hang L, Stephens-Larson P, Henry J, Dixon F. The role of hypertension in the vascular disease and myocardial infarcts associated with murine systemic lupus erythematosus. Arthritis Rheum. 1989;26:1340-1345.
8. 1 mice: a model of antiphospholipid syndrome. J Immunol. 1992;149:1063-1068.
9. 1 mice. Blood. 1993;82:837-844.
10. Accinni L, Dixon FJ. Degenerative vascular disease and myocardial infarction in mice with lupus-like syndrome. Am J Pathol. 1979;96:477-492.
11. Bidani A, Roberts J, Schwartz M, Lewis E. Immunopathology of cardiac lesions in fatal systemic lupus erythematosus. Am J Med. 1980;69:849-858.
12. Berden J, Hang L, McConahey P, Dixon F. Analysis of vascular lesions in murine SLE. I: association with serologic abnormalities. J Immunol. 1983;130:1699-1705.
13. Harris EN, Gharavi AE, Hughes GRV. Anti-phospholipid antibodies. Clin Rheum Dis. 1985;11:591-609.
14. 1 mice. Proc Natl Acad Sci USA. 1994;91:4402-4406.
15. 1 and normal mice. Blood. 1990;75:1809-1812.
16. 1 hybrid mice immunosuppressed with total lymphoid irradiation and in reconstituted bone marrow chimeras. J Clin Lab Immunol. 1983;10:185-191.
17. Ikehara SR, Good RA, Nakamura T, et al. Rationale for bone marrow transplantation in the treatment of autoimmune diseases. Proc Natl Acad Sci U S A. 1985;82:2483-2487.
18. Ikehara S, Kawamura M, Takao F, et al. Organ-specific and systemic autoimmune diseases originate from defects in hematopoietic stem cells. Proc Natl Acad Sci U S A. 1990;87:8341-8344.
19. Kincade PW, Lee G, Fernandes G, Moore MAS, Williams N, Good RA. Abnormalities in clonable B lymphocytes and myeloid progenitors in autoimmune NZB mice. Proc Natl Acad Sci U S A. 1979;76:3464-3468.
20. Kotzin BL, Strober S. Reversal of nzb/nzw disease with total lymphoid irradiation. J Exp Med. 1979;150:371-378.
21. Warner NL, Moore MAS. Defects in hematopoietic differentiation inNZB and NZC mice. J Exp Med. 1971;134:313-334.
22. Jyonouchi H, Kincade PW, Good RA, Fernandes G. Reciprocal transfer of abnormalities in clonable B lymphocytes and myeloid progenitors between NZB and DBA/2 mice. J Immunol. 1981; 127:1232-1235.
23. Morton JI, Siegel BV. Transplantation of autoimmune potential. I: development of antinuclear antibodies in H-2 histocompatible recipients of bone marrow from New Zealand black mice. Proc Natl Acad Sci U S A. 1974;71:2162-2165.
24. Morton JI, Siegel BV. Transplantation of autoimmune potential. IV: reversal of the NZB autoimmune syndrome by bone marrow transplantation. Transplantation. 1979;27:133-134.
25. Haider YS, Roberts WC. Coronary arterial disease in systemic lupus erythematosus: quantification of degrees of narrowing in 22 necropsy patients (21 women) aged 16 to 37 years. Am J Med. 1981;70:775-781.
26. Good RA, Kapoor N, Reisner Y. Bone marrow transplantation: an expanding approach to treatment of many diseases. Cell Immunol. 1983;82:36-54.
27. Harrison DE, Zhong R. The same exhaustible multilineage precursor produces both myeloid and lymphoid cells as early as 3-4 weeks after marrow transplantation. Proc Natl Acad Sci U S A. 1992;89:10134-10138.
28. Spangrude G, Heimfeld S, Weissman I. Purification and characterization of mouse hematopoietic stem cells. Science. 1988;241:58-62.
29. Golde D. The stem cell. Sci Am. 1991;265:86-93.